Feedback / Questions
sodium oxybate ER (FT218) - Avadel
https://www.globenewswire.com/news-release/2021/04/17/2211918/0/en/Avadel-Presents-New-Data-from-its-Pivotal-REST-ON-Phase-3-Trial-of-FT218-once-nightly-sodium-oxybate-at-the-2021-American-Academy-of-Neurology-Annual-Meeting.html
Apr 17, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next